Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis
When sodium-glucose cotransporter-2 (SGLT2) inhibitors were first introduced a decade ago, no one expected them to have substantial effects beyond their known glucose-lowering effects, until the emergence of evidence of their robust renal and cardiovascular benefits showing that they could attenuate...
Main Authors: | Eun Sil Koh, Gheun-Ho Kim, Sungjin Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Endocrine Society
2023-08-01
|
Series: | Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.e-enm.org/upload/pdf/enm-2023-1764.pdf |
Similar Items
-
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
by: Jun Tang, et al.
Published: (2022-02-01) -
Changes of natriuresis and prediction of cardiovascular events in patients with type 2 diabetes and decompensated heart failure over therapy with sodium-glucose cotransporter 2 inhibitors and standard diuretic therapy
by: O. A. Abdullaev, et al.
Published: (2024-03-01) -
Impairment of natriuresis and diuresis induced by intrarenal adrenoceptor mechanisms in an experimental model of cirrhosis in rats
by: Maycon I.O. Milanez, et al.
Published: (2019-12-01) -
Renal glucose handling in diabetes and sodium glucose cotransporter 2 inhibition
by: Resham Raj Poudel
Published: (2013-01-01) -
Pressure-Natriuresis Response Is Diminished in Old Age
by: Yang Gyun Kim, et al.
Published: (2022-02-01)